Arla Foods Ingredients: Pioneering Dairy Innovation

Company Overview

Arla Foods Ingredients (AFI) is at the forefront of the dairy-derived ingredients sector, with its headquarters located in Viby, Denmark. The company has established itself as a pioneer in developing innovative food ingredients catering to various sectors, including infant formula and sports nutrition.

Facilities and Operations

AFI operates a state-of-the-art production facility in Videbæk, Denmark, equipped with cutting-edge technology to produce high-quality dairy ingredients. Additionally, the company has an Innovation Center in Aarhus, Denmark, dedicated to the research and development of groundbreaking food ingredients.

Leadership

Under the leadership of CEO Henrik Andersen, Arla Foods Ingredients has experienced significant growth and innovation. Andersen's strategic vision has been crucial in propelling the company forward within the dairy industry.

Financial Indicators

Arla Foods Ingredients reported revenues exceeding EUR 800 million, contributing approximately 10% to the total revenue of the Arla Foods Group. The company achieved an impressive revenue growth of 43.1%, reaching EUR 1.452 billion. In the first six months of 2026, AFI generated €867 million in revenue.

Important Company Events

• 2019: Expanded operational capacity with a new lactose manufacturing site in Nr. Vium, Denmark.
• 2021: Launched its first organic micellar casein isolate.
• 2022: Introduced Nutrilac® FO-7875 and acquired Volac’s Whey Nutrition business. Partnered with First Milk for whey protein production and completed a project to change the heating arrangement at production tower 4 at the Danmark Protein facility.
• 2024: Launched Lacprodan DI-3092, a whey hydrolysate with low lactose levels and a hydrolysis degree of 16–22%.

Company Plans

Arla Foods Ingredients is committed to an ambitious growth strategy, focusing on expanding production capabilities in Asia and the Americas, and investing in research for sports, infant, and medical nutrition products. Sustainability is a key aspect, aiming to reduce carbon emissions and enhance energy efficiency. The company adapts to new regulatory changes, allowing the declaration of milk fat globule membrane (MFGM) on products across the EU, and has launched Whey360 to emphasize MFGM benefits. AFI is expanding its distribution partnership with the Brenntag Group to Southeast Asia and entering the performance nutrition market in ANZ/Oceania through a new partnership with Alchemy Agencies. The company plans to showcase new high-protein food and beverage concepts at the Fi Europe event in Paris and introduce its protein bar concept in South America at the Nutri Ingredients Summit in Brazil. A clinical study has confirmed that Arla Foods Ingredients' Lacprodan IF-3070 supports healthy infant growth. AFI will present high-protein, nutrient-dense concepts at Vitafoods Europe 2026, focusing on GLP-1 anti-obesity medications. The company will showcase shake innovations at SupplySide Global, presenting personalized clear-shake concepts and working with the RENEW project on calcium-rich ingredients. The production facility at the Arla Foods Ingredients site in Felinfach will provide additional production space, offices, laboratory accommodation, and storage silos and tanks. AFI will exhibit at Fi Europe in Frankfurt, showcasing products for GLP-1 users, active nutrition, and other food applications, including new yogurt formats and protein shots, with a focus on their whey permeate ingredient, Variolac.